Shanghai Genechem Co., Ltd. announced that it has received CNY 100,000,000 in a round of funding in January 2016. The transaction included participation from investors including HighLight Capital, China Renaissance Partners, Investment Arm, and returning investor Jiangsu Aoyang Health Industry Co.ltd. (SZSE:002172)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 CNY | 0.00% | +3.28% | -16.89% |
1st Jan change | Capi. | |
---|---|---|
-16.89% | 334M | |
+6.48% | 3.19B | |
-1.79% | 1.19B | |
+52.32% | 933M | |
-10.37% | 917M | |
+9.32% | 848M | |
-4.55% | 768M | |
+27.10% | 601M | |
+18.95% | 537M | |
-17.49% | 438M |
- Stock Market
- Equities
- 002172 Stock
- News Jiangsu Aoyang Health Industry Co.ltd.
- Shanghai Genechem Co., Ltd. announced that it has received CNY 100 million in funding from HighLight Capital, China Renaissance Partners, Investment Arm, Jiangsu Aoyang Health Industry Co.ltd. and other investors